Despite a holiday-shortened week, a slew of major earnings reports from diverse industries is still set to grab investors' ...

About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

With just over 100 days as CEO now under her belt, Catherine Owen Adams is looking to cruise rare disease-focused Acadia ...

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the ...

Legend Biotech Corporation (NASDAQ:LEGN) is a clinical-stage company that develops, discovers, manufactures, and ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

Central New York plow companies have been keeping busy this winter season, including Pro Snow Removal in LaFayette. “It’s ...

The FDA’s move comes more than a year after California Gov. Gavin Newsom signed the California Food Safety Act, which bans ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational ...